These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22971295)

  • 1. [Renal disease by type 2 diabetes].
    Persson F; Rossing P
    Ugeskr Laeger; 2012 Sep; 174(37):2150-4. PubMed ID: 22971295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserving the diabetic kidney.
    Poirier SJ
    J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 7. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy--the family physician's role.
    Roett MA; Liegl S; Jabbarpour Y
    Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus.
    Corradi L; Zoppi A; Tettamanti F; Malamani G; Lazzari P; Fogari R
    J Hypertens Suppl; 1993 Dec; 11(5):S190-1. PubMed ID: 8158337
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
    Nelson RG; Bennett PH; Beck GJ; Tan M; Knowler WC; Mitch WE; Hirschman GH; Myers BD
    N Engl J Med; 1996 Nov; 335(22):1636-42. PubMed ID: 8929360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremia (end-stage renal disease): how cost-effective are preventive strategies?
    Glassock RJ
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S131-4. PubMed ID: 20797562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
    Conti AA
    Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas transplantation for the prevention of diabetic nephropathy.
    Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
    Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural history of diabetic nephropathy].
    Ishimura E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():324-30. PubMed ID: 15999728
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.